<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <fn-group id="onco13337-ntgp-0101">
  <fn id="onco13337-note-0101" fn-type="COI-statement">
   <p>
    <italic>Disclosures of potential conflicts of interest may be found at the end of this article</italic>.
   </p>
  </fn>
  <fn id="onco12665-note-1001">
   <p>
    <bold>Editor's Note:</bold> In this issue, see also the following articles related to COVID‐19 and how it impacts the care of cancer patients:“Cancer Research Ethics and COVID‐19,” by Andrew G. Shuman and Rebecca D. Pentz, on page 
    <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.1634/theoncologist.2020-0221" xmlns:xlink="http://www.w3.org/1999/xlink">458</ext-link> “How to Guarantee the Best of Care to Patients with Cancer During the COVID‐19 Epidemic: The Italian Experience,” by Giuseppe Curigliano, on page 
    <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.1634/theoncologist.2020-0267" xmlns:xlink="http://www.w3.org/1999/xlink">463</ext-link> “Breaking Bad News via Telemedicine: A New Challenge at Times of an Epidemic,” by Ido Wolf, Barliz Waissengrin, Sharon Pelles, on page 
    <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.1634/theoncologist.2020-0284" xmlns:xlink="http://www.w3.org/1999/xlink">e879</ext-link> (online only)“A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative Group,” by Humaid O. Al‐Shamsi, Waleed Alhazzani, Ahmad Alhuraiji et al., on page 
    <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.1634/theoncologist.2020-0213" xmlns:xlink="http://www.w3.org/1999/xlink">e936</ext-link> (online only)
   </p>
  </fn>
  <fn id="onco13337-note-0102">
   <p>No part of this article may be reproduced, stored, or transmitted in any form or for any means without the prior permission in writing from the copyright holder. For information on purchasing reprints contact 
    <email>Commercialreprints@wiley.com</email>. For permission information contact 
    <email>permissions@wiley.com</email>.
   </p>
  </fn>
 </fn-group>
</notes>
